| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
| 12/27/2007 | WO2007149557A1 FUSED [d]PYRIDAZIN-7-ONES |
| 12/27/2007 | WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | WO2007148950A1 Synergistic pharmaceutical composition of ketorolac and lysine clonixinate |
| 12/27/2007 | WO2007148837A1 Composition capable of promoting the production of collagen |
| 12/27/2007 | WO2007148804A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148803A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148786A1 Stabilized solid preparation |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 12/27/2007 | WO2007148474A1 Preparation for external application to skin containing triterpenic acid |
| 12/27/2007 | WO2007148094A1 Cannabinoids for use in the treatment of neuropathic pain |
| 12/27/2007 | WO2007147577A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them |
| 12/27/2007 | WO2007147556A1 Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain |
| 12/27/2007 | WO2007125321A3 Purine and deazapurine derivatives as pharmaceutical compounds |
| 12/27/2007 | WO2007120980A3 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 12/27/2007 | WO2006129158B1 3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i |
| 12/27/2007 | WO2005030228A3 Use of a composition containing extracts of vitis vinifera and lycopersicum for protecting the skin |
| 12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
| 12/27/2007 | US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 12/27/2007 | US20070299124 Formulations and methods for treating dry eye |
| 12/27/2007 | US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use |
| 12/27/2007 | US20070299100 Analgesic |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/27/2007 | US20070299047 Combination of Organic Compounds |
| 12/27/2007 | US20070299044 Corticosteroid Topical Dispersion with Low Content of Surfactant |
| 12/27/2007 | US20070298124 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits |
| 12/27/2007 | US20070298102 Extended Release Pharmaceutical Composition of Celecoxib |
| 12/27/2007 | US20070298089 Drug for External Use and Adhesive Patch |
| 12/27/2007 | US20070298058 Pharmaceutical compositions comprising ascomycin |
| 12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 12/27/2007 | US20070298035 Recombinant immunoglobulin for targeting, treatment and prevention of cancer, transplant rejection and viral infection |
| 12/27/2007 | US20070298031 Methods for preventing or treating neuromuscular or muscular conditions by peripherally administered erythropoietin |
| 12/27/2007 | US20070298011 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 12/27/2007 | US20070297989 Novel anti-inflammatory androstane derivatives |
| 12/27/2007 | US20070297982 Preparation And Composition Of Inter-Alpha Inhibitor Proteins From Human Plasma For Therapeutic Use |
| 12/27/2007 | US20070297981 Formulations and methods for treating dry eye |
| 12/27/2007 | US20070297977 TNF-gamma-beta polypeptides whose antagonists are used as a therapeutic to treat cachexia, septic shock, cerebral malaria, inflammation, arthritis and graft-rejection |
| 12/27/2007 | DE202006020214U1 Mittel zur Beeinflussung der Nozizeption und deren Folgen Means for influencing the nociception and its consequences |
| 12/27/2007 | DE102006029447A1 Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel Oxo-substituted imidazo [1,2-b] pyridazines, their preparation and use as medicaments |
| 12/27/2007 | DE102006029233A1 Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika Formulations to improve the compatibility of non-steroidal anti-inflammatory drugs |
| 12/27/2007 | CA2656698A1 Cannabinoids for use in the treatment of neuropathic pain |
| 12/27/2007 | CA2656370A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them |
| 12/27/2007 | CA2656361A1 Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain |
| 12/27/2007 | CA2656034A1 Fused [d]pyridazin-7-ones |
| 12/27/2007 | CA2655788A1 Skin external preparation containing triterpenic acid |
| 12/27/2007 | CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | CA2648993A1 Grafted polymers and uses thereof |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870410A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 12/26/2007 | EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/26/2007 | EP1870105A1 Use of fucans in the treatment of psoriasis |
| 12/26/2007 | EP1870095A1 Composition for increasing anti-oxidation activity in blood |
| 12/26/2007 | EP1869053A1 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and their use in the production of medicaments |
| 12/26/2007 | EP1869013A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 12/26/2007 | EP1869012A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases |
| 12/26/2007 | EP1869006A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 12/26/2007 | EP1868986A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 12/26/2007 | EP1868612A2 Novel compounds |
| 12/26/2007 | EP1868611A2 Novel compounds |
| 12/26/2007 | EP1868609A2 Prokineticin 1 receptor |
| 12/26/2007 | EP1868605A2 Phenyl and pyridyl lta4h modulators |
| 12/26/2007 | EP1868603A1 DERIVATIVES OF Ý6,7-DIHYDRO-5HIMIDAZO Ýl,2-ALPHA¨IMIDAZOLE-3-SULFONYL¨-AZETEDINE-CARBOXYLIC ACIDS, ESTERS AND AMIDES AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS |
| 12/26/2007 | EP1868596A1 Use of lactobacillus rhamnosus gg in combination with a long chain polyunsaturated fatty acid for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant |
| 12/26/2007 | EP1799214B1 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/26/2007 | EP0837630B1 Prodrugs of pharmaceuticals with improved bioavailability |
| 12/26/2007 | CN101094832A Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 12/26/2007 | CN101094674A Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 12/26/2007 | CN101094662A Hydrous adhesive patch |
| 12/26/2007 | CN101094659A Nanoparticle composition and methods for synthesis thereof |
| 12/26/2007 | CN101092397A Structure modified compound of sinomenine, and prepartion method |
| 12/26/2007 | CN101091795A Prevention and treatment of synucleinopathic disease |
| 12/26/2007 | CN101091767A Anti-inflammation, dissolving lumps, and ease pain paste, and preparation method |
| 12/26/2007 | CN101091734A Method for preparing extractive of pubescent angelica root coumarin |
| 12/26/2007 | CN101091717A Medicine to lower the temperature in use for pigs and preparation method |
| 12/26/2007 | CN101091707A Medicinal usage of kuhseng extractive |
| 12/26/2007 | CN100357324C Effectors of innate immunity |
| 12/26/2007 | CN100357293C Diazinopyrimidines |
| 12/26/2007 | CN100357282C Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same |
| 12/26/2007 | CN100357277C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 12/26/2007 | CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100357244C Aspirin-triggered lipid mediators |
| 12/26/2007 | CN100356971C Application of botanical medicinal composition in the preparation of gynecopathy treating medicine |
| 12/26/2007 | CN100356937C External use prepns. for wind-dispelling, removing-obstruction in channels to relieve pain |
| 12/26/2007 | CN100356936C Medicine oil for relaxing joints and its prepn |
| 12/26/2007 | CN100356928C Use of red yeast in preparing anti-inflammatory medicine |
| 12/25/2007 | US7312344 Dimeric isoflavones |
| 12/25/2007 | US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically |
| 12/25/2007 | US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders |
| 12/25/2007 | US7312321 Antibody to human enzymes of the metalloprotease family |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312224 Pyrimidine derivatives |
| 12/25/2007 | US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis |
| 12/25/2007 | US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/25/2007 | US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |